KELLY WERKMEISTER: Open Payments
NPI 1346293826 · LANCASTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 14 payments from 9 companies in 2025. Trend: 2023 $175 · 2024 $233 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Novo Nordisk Inc | 2 | $43 |
| ABIOMED | 2 | $35 |
| ABBVIE INC. | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Insulet Corporation | 1 | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: Kerendia, Ozempic, ONPATTRO, Omnipod, LifeVest, QULIPTA, Wegovy, CAPVAXIVE.
Industry payments across KY — which companies pay providers there.
